Used in biomedical research to quantify levels of CPT1α, a key enzyme involved in fatty acid metabolism, in human tissue samples and cell lysates. This kit enables researchers to study metabolic disorders such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease by measuring changes in CPT1α expression under different experimental conditions. It is also applied in drug development to assess the impact of therapeutic compounds on mitochondrial fatty acid oxidation pathways. The assay supports high-throughput analysis in clinical research settings, helping to identify potential biomarkers related to energy metabolism and insulin resistance.